Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal of shareholdings in Euroclear plc

24 Oct 2017 17:37

RNS Number : 5129U
Royal Bank of Scotland Group PLC
24 October 2017
 

Royal Bank of Scotland Group PLC

24 October 2017

 

Disposal of shareholdings in Euroclear plc

 

The Royal Bank of Scotland Group plc ("RBS") announces that its subsidiaries have today entered into an agreement to dispose of RBS' entire shareholdings in Euroclear plc to IntercontinentalExchange Holdings.

 

The transaction, which was also completed today, involved the sale of 148,349 ordinary shares in Euroclear plc for a total cash consideration of €275 million (approximately £245 million at current exchange rates)*. KPMG Corporate Finance acted as financial advisers to RBS and Simmons & Simmons acted as legal advisers to RBS on this transaction.

 

The sale proceeds will be used for general corporate purposes. The transaction is part of the continued reduction of assets in RBS and is in line with the bank's plan to strengthen its capital position.The carrying value of the shareholding in Euroclear plc as at 30 June 2017 was approximately £88 million, which represents RWA equivalent of around £220 million. The transaction is expected to generate a gain of approximately £175 million after associated costs, reserves recycling and before tax, which will be recognised as a gain on strategic disposal in Q4 2017.

 

For further information, please contact:

RBS Investor RelationsMatt WaymarkHead of Investor RelationsTel: +44 (0) 20 7672 1758

 * Under the terms of the sale agreement, additional consideration may become payable in certain circumstances if the purchaser either resells Euroclear plc shares acquired pursuant to this transaction or acquires further shares in Euroclear plc, in each case at or above certain agreed pricing thresholds within a specified period following completion.

FORWARD LOOKING STATEMENTS

This announcement contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, including (but not limited to) those with respect to RBS and its subsidiaries' regulatory capital position, financial position, risk-weighted assets, profitability and financial performance and the implementation of RBS's transformation programme under certain specified scenarios. In addition, forward-looking statements may include, without limitation, statements containing words such as "intends", "believes", "expects", "anticipates", "targets", "plans", "will" and similar expressions or variations on these expressions. These statements concern or may affect future matters, such as RBS's future economic results, business and capital plans and ability to achieve current strategies. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed in, or implied by, the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, political, fiscal and regulatory developments, accounting standards, competitive conditions, technological developments, interest and exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBS's actual results are discussed in RBS's 2016 Annual Report and Accounts (ARA) and its interim results for the six-months ended 30 June 2017 and materials filed with, or furnished to, the United States Securities and Exchange Commission, including, but not limited to, RBS's most recent Annual Report on Form 20-F and Reports on Form 6-K. The forward-looking statements contained in this announcement speak only as of the date they are made or revised and RBS does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, except to the extent legally required.

Legal Entity Identifier: 2138005O9XJIJN4JPN90, RR3QWICWWIPCS8A4S074

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISMIBFTMBTTBFR
Date   Source Headline
2nd Aug 20137:00 amRNSInterim Results - Part 2 of 7
2nd Aug 20137:00 amRNSInterim Results - Part 1 of 7
2nd Aug 20137:00 amRNSDirectorate Change
31st Jul 20134:49 pmRNSTotal Voting Rights
31st Jul 201312:31 pmRNSHolding(s) in Company
24th Jul 20133:57 pmRNSRestatement Document
17th Jul 20136:18 pmRNSAllotment and Issue of New Ordinary Shares
9th Jul 20132:03 pmRNSDirector/PDMR Shareholding
2nd Jul 20136:03 pmRNSPublication of Prospectus
2nd Jul 201312:50 pmRNSRBS Investor Seminar on its Ulster Bank Business
1st Jul 201310:27 amRNSRBS NV ANNOUNCES CASH TENDER OFFER FINAL RESULTS
28th Jun 20134:23 pmRNSTotal Voting Rights
20th Jun 20137:08 amRNSFPC Capital Requirements
17th Jun 201312:36 pmRNSRBS NV Increases Tender Cap and Announces Results
13th Jun 20137:50 amRNSGoldman Sachs European Financials Conference
12th Jun 20135:10 pmRNSDirectorate Change
12th Jun 20131:54 pmRNSRBSG RESUMES NV TPS DIVIDEND PAYMENTS
11th Jun 20131:31 pmRNSRBS NV calls ABN EUR77M Zero Coupon Notes due 2029
11th Jun 201312:49 pmRNSRBS NV calls ABN ?77M Zero Coupon Notes due 2029
10th Jun 20133:22 pmRNSDirector/PDMR Shareholding
7th Jun 20132:30 pmRNSDirector/PDMR Shareholding
4th Jun 201310:53 amRNSRBSG plc priced $1bn 10 yr Tier 2 security
3rd Jun 20132:14 pmRNSRBS NV tender offer for certain capital securities
31st May 20134:50 pmRNSTotal Voting Rights
24th May 20133:48 pmRNSDividend Declaration
22nd May 20132:30 pmRNSDirector/PDMR Shareholding
22nd May 201310:51 amRNSRBS Update on Capital Position
17th May 201312:39 pmRNSPublication of Prospectus
14th May 20135:48 pmRNSResult of Meeting
14th May 20135:46 pmRNSResult of AGM
14th May 20132:00 pmRNSAGM Statement
9th May 20131:40 pmRNSRBS announces planned management changes
8th May 201311:24 amRNSDirector/PDMR Shareholding
3rd May 20137:00 amRNSInterim Management Statement - Part 5 of 5
3rd May 20137:00 amRNSInterim Management Statement - Part 4 of 5
3rd May 20137:00 amRNSInterim Management Statement - Part 3 of 5
3rd May 20137:00 amRNSInterim Management Statement - Part 2 of 5
3rd May 20137:00 amRNSInterim Management Statement - Part 1 of 5
30th Apr 20135:08 pmRNSTotal Voting Rights
26th Apr 20132:37 pmRNSNotice of General Meeting
25th Apr 20132:51 pmRNSPublication of Prospectus
23rd Apr 20135:36 pmRNSDividend Declaration
23rd Apr 201310:43 amRNSCALL DECISION&POLICY ON CERTAIN RBS NV SECURITIES
9th Apr 20133:03 pmRNSDirector/PDMR Shareholding
9th Apr 20139:38 amRNSNotice of AGM 'Replacement'
9th Apr 20139:16 amRNSNotice of AGM
5th Apr 20131:27 pmRNSAdditional Block Listing
3rd Apr 20134:07 pmRNSNotification of Major Interest in Shares
28th Mar 20135:14 pmRNSTotal Voting Rights
28th Mar 20137:05 amRNSFiling of Annual Report on Form 20-F With US SEC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.